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W
orld Kidney Day on 8 March 2012 
provides a chance to reflect on the 
success of kidney transplantation as 
a therapy for end-stage renal dis-
ease (ESRD) that surpasses dialysis treatments for 
the quality and quantity of life and for cost effec-
tiveness. An experimental, risky, and very limited 
treatment option 50 years ago is now routine 
clinical practice in more than 80 countries. What 
was limited to a few people in a small number of 
academic centers is now routinely transforming 
lives in most high- and medium-income coun-
tries. The largest numbers of transplantations are 
performed in the United States, China, Brazil, 
and India, while the greatest population access 
to transplantation is in Croatia, Portugal, Spain, 
Austria, the United States, and Norway, but 
almost all countries have growing waiting lists, 
and transplantation meets only 10% of the global 
need. Barriers to broader application include, of 
course, economic limitations that appropriately 
place transplantation at a lower priority than 
clean water, sanitation, and vaccination. Even in 
high-income countries, the technical challenges 
of surgery and the consequences of immunosup-
pression restrict the number of suitable recipients, 
but the major restrictions on kidney transplanta-
tion rates are the shortage of donated organs and 
the small size of trained medical, surgical, and 
nursing workforces with the required expertise.
The first successful organ transplantation 
occurred between identical twins in Boston on 
23 December 1954. Between 1965 and 1980, 
patient survival progressively improved to 90%, 
and graft survival rose to at least 60%. Thirty years 
on, unsensitized recipients of first deceased- or 
living-donor kidney transplants can expect 1-year 
patient survival of 95% and transplant survival of 
at least 90%. Recent developments have also led to 
excellent results from ABO blood group-incom-
patible transplants in recipients with low-titer 
ABO antibodies. High titers of donor-specific 
human leukocyte antigen antibodies have also 
limited patients’ prospects for transplantation, but 
better desensitization protocols and paired kidney 
exchange programs now afford real opportunities 
for those previously deemed untransplantable. 
Kidney transplantation provides both better qual-
ity and quantity of life than maintenance dialy-
sis. In the United States between 1991 and 1997, 
mortality was 68% lower in transplant recipients 
than in those remaining on the transplant waiting 
list after more than 3 years of follow-up; 20- to 
39-year-old patients with transplants were pre-
dicted to live 17 years longer than those remain-
ing on the waiting list.
In Pakistan, Rizvi has shown that it is pos-
sible, despite the resource-poor environment, 
to achieve 1- and 5-year survival rates of 92% 
and 85%, respectively, but across the world, 
ethnic minorities, disadvantaged populations, 
and African Americans generally suffer worse 
outcomes when compared with white patients. 
Although it is possible to achieve excellent long-
term results in resource-poor environments, most 
patients and their families are not able to afford 
the high-cost immunosuppressants and antiviral 
medications that reduce the risk of graft loss and 
mortality.
Worldwide, the number of potential candidates 
for renal replacement therapy is growing rapidly, 
but long-term dialysis, expensive for developed 
countries, is prohibitive for most emerging econ-
omies. It is critical to recognize that funding of 
ESRD treatment must be preceded by, and linked 
to, strategies to identify and prevent progressive 
chronic kidney diseases. The majority of patients 
commencing dialysis in low-income countries 
die or stop treatment within the first 3 months 
of dialysis because of cost. Transplantation, 
especially when preemptive of dialysis, provides 
a mechanism to both expand access and reduce 
costs for successful treatment of ESRD.
There are substantial disparities in access to 
transplantation across the world (Figure 1). The 
relationship between transplantation rate and 
each nation’s Human Development Index (HDI) 
shows not only the reduced transplantation rate 
in the low- and middle-HDI countries but also 
the large spread of rates even among the richer 
nations. Kidney transplantation rates of more 
than 30 per million population (pmp) in 2010 
were restricted to Western Europe, the United 
States, and Australia, with a slightly broader 
spread of countries achieving between 20 and 
30 pmp. In addition to this variability, there are 
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substantial within-country disparities in trans-
plantation rates among women, and ethnic 
minorities. Even in the United States, with high 
overall transplantation rates, African Americans, 
women, and the poor fare badly compared with 
Caucasians, men, and the affluent.
Developing countries suffer poor transplan-
tation rates because of a combination of low 
levels of infrastructure; an insufficient trained 
workforce; lack of a legal framework governing 
brain death; religious, cultural, and social con-
straints; patient apprehension; physician bias; 
commercial incentives favoring dialysis; and 
geograph ical remoteness. Poor access to trans-
plantation is therefore almost inevitable for most 
of the world’s population.
Both living donation and deceased-donor 
donation are recognized by the WHO (World 
Health Organization) to go hand in hand with 
prevention programs as critical to the capacity 
of nations to develop self-sufficiency for man-
agement of ESRD. No country in the world gen-
erates sufficient organs to meet the needs of its 
citizens. Spain, Croatia, Portugal, Austria, the 
United States, and Norway stand out as coun-
tries with high rates of deceased organ donors, 
and most countries are trying to emulate their 
success. A return to donation after cardiac death, 
instead of the now-standard donation after brain 
death, has enhanced the numbers of deceased 
organ donations in several countries. Extended-
criteria donor kidneys are less successful in the 
long term but are accepted by patients with 
limited alternatives.
A number of strategies have been imple-
mented to reduce the disparities. The Trans-
plantation Society has established the Global 
Alliance for Transplantation to collect and 
disseminate global information, expand educa-
tion in transplantation, and develop guidelines 
for organ donation and transplantation. The 
International Society of Nephrology Global 
Outreach Program has catalyzed the develop-
ment of kidney transplant programs across a 
large number of countries with targeted fel-
lowship training and stimulation of long-term 
institutional links between developed and devel-
oping transplant centers. The establishment of 
national ESRD registries; training programs for 
nephrologists, transplant surgeons, nursing staff, 
and donor coordinators; and nationally funded 
organ procurement organizations providing 
transparent and equitable retrieval and alloca-
tion also offer an opportunity to improve access 
to transplantation worldwide.
The reality of the global organ-donor short-
age is, however, that in general, the rich receive 
more transplants than the poor, either from their 
own country or with an organ illegally purchased 
from the poor or taken from an executed Chinese 
prisoner. Trafficking in and commercialization 
of human organs changed from an unusual and 
extremely hazardous practice in the 1980s, to a 
frequent but still very hazardous one in the 1990s, 
and then to a gruesomely burgeoning trade from 
the turn of the century. The WHO estimated that 
up to 10% of all organ transplants were of com-
mercial origin by 2005.
Figure 1 | Number of deceased- and living-donor kidney transplants in WHO (World Health Organization) 
Member States in 2010, correlated with Human Development Index. Grouped by WHO regions (AFR, Africa; 
AMR, Americas; EMR, Eastern Mediterranean; EUR, Europe; SEAR, South-East Asia; WPR, Western Pacific).
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The first WHO Guiding Principles in this 
field were endorsed in 1991, making clear the 
decision of all national governments to ban 
commercialization of the human body. This prin-
ciple was reaffirmed unanimously by the World 
Health Assembly in 2010 when the updated WHO 
guiding principles for human organ and tissue 
donation and transplantation were endorsed. Iran, 
alone, claims to have resolved national self-suffi-
ciency for renal transplantation through a scheme 
of part government-funded, part patient-funded 
sale of kidneys by vendors. All other countries with 
transplantation programs have carried that ban 
on commercialism into their own legislation. It is 
thus illegal to buy or sell organs even in the major 
human-organ-trafficking countries of the world. 
Sadly, this has not prevented illegal continuation of 
the trade in countries such as China and Pakistan, 
nor has it prevented new entrants to this lucrative 
trade from taking advantage of their own or other 
nations’ impoverished and vulnerable populations 
to provide kidneys and even livers for the desperate 
wealthy in need of transplantation.
The Transplantation Society and the Interna-
tional Society of Nephrology took a joint stand 
against the despoiling of transplantation therapy 
and victimization of the poor and vulnerable by 
doctors, brokers, and hospitals operating these 
illegal programs. In 2008, more than 150 rep-
resentatives from across the world from differ-
ent disciplines of health care, national policy 
development, law, and ethics produced the Decla-
ration of Istanbul, which has now been endorsed 
by more than 110 professional and governmental 
organizations and implemented by many of these 
organizations with a goal to eliminate transplant 
tourism and enhance the ethical practice of trans-
plantation globally.
Major challenges remain in providing opti-
mal management of ESRD, particularly in low-
income economies. There is a need to mandate 
more focus on community screening and imple-
mentation of simple measures to minimize 
progression of chronic kidney disease. The recent 
designation, by the United Nations High-Level 
Meeting, of renal disease as an important non-
communicable disease is one step in the right 
direction.
There are transplantation solutions available 
that need augmentation across all economies. 
These include replication of the demonstrably 
successful models of kidney transplant programs 
in many developing countries; efforts to grow 
the availability of less expensive generic immu-
nosuppressive agents; improved clinical training 
opportunities; governmental and professional 
guidelines legislating prohibition of commer-
cialization and defining professional standards 
of ethical practice; and a framework for each 
nation to develop self-sufficiency in organ trans-
plantation through focus on both living dona-
tion and nationally managed deceased organ 
donation programs.
The International Society of Nephrology and 
the Transplantation Society have pledged to 
work together in coordinated joint global out-
reach programs to help establish and grow appro-
priate kidney transplant programs in low- and 
middle-income countries utilizing their consid-
erable joint expertise. World Kidney Day 2012 
provides a focus to help spread this message to 
governments, health authorities, and communi-
ties across the world on 8 March 2012.
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